跳至主要内容
临床试验/NCT01199276
NCT01199276已完成2 期

An International, Multi-center, Randomized, Controlled Trial Evaluating The Effect of Xenon on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery

Air Liquide Santé International13 个研究点 分布在 6 个国家目标入组 256 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
256
试验地点
13
主要终点
Post Operative Delirium diagnosed with the Confusion Assessment Method within four days post-surgery

研究概览

简要总结

The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD), diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip fracture surgery under general anaesthesia with xenon or sevoflurane, for a period of four days post-surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elderly patient (≥ 75 years)
  • Patient with planned hip fracture surgery within 48 hours after the hip fracture
  • Patient willing and able to complete the requirements of this study including the signature of the written informed consent

排除标准

  • Patient suffering from multiple fractures, pelvic fractures proximal, pathological fractures, femur fractures (i.e., fractures of the middle or distal femur)
  • Disabling neuropsychiatric disorders (severe dementia, Alzheimer's disease, schizophrenia, depression)
  • Brain trauma within 12 months prior to selection, history of stroke with residuals
  • Patient suffering from delirium (CAM diagnosis) at selection
  • Patient who cannot complete the pre-operative mental tests (CAM and/or MMSE) of this clinical trial
  • Patient with Mini-Mental State Examination (MMSE) score < 24 at selection
  • Patient known to susceptible to malignant hyperthermia
  • Patient with elevated intra-cranial pressure
  • Patient with a risk of high oxygen demand
  • Patient with recent or ongoing myocardial infarction / damage
  • Patient with severe cardiac failure, or patient with severe impaired left ventricular systolic function
  • Patient with known severe lung and/or airway disease, or severe chronic respiratory insufficiency, or a sustained homecare oxygen therapy
  • Contra-indication (serious illness or medical conditions) for general anaesthesia
  • Known allergy or hypersensitivity to any drugs administered during this clinical trial
  • Previous participation in this clinical trial
  • Participation in another clinical trial within 4 weeks prior to selection
  • History of alcohol or drug abuse or psychiatric disorders which would impair the understanding of the necessary information or render medically or legally unable to give written informed consent

研究组 & 干预措施

Xenon

Experimental

60%(1MAC)in oxygen (FiO2 = 0.35-0.45)

干预措施: Xenon (Drug)

Sevoflurane

Active Comparator

1.1-1.4% (1 MAC) in oxygen (FiO2 = 0.35-0.45) and medical air

干预措施: Sevoflurane (Drug)

结局指标

主要结局

Post Operative Delirium diagnosed with the Confusion Assessment Method within four days post-surgery

时间窗: Four days

次要结局

  • Recovery Parameters(fifteen minutes)
  • Post Operative Delirium diagnosed with the Confusion Assessment Method from day 5 post surgery to discharge from hospital(About 7 days)
  • Sequential Organ Failure Assessment from day 1 to day 4 post-surgery(four days)
  • economic parameters(up to thirty days)
  • Safety Parameters(Up to thirty days)

研究者

发起方
Air Liquide Santé International
申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验